Skip to Main Content

Paper Details

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
Lancet Neurol
161
2022
CAA, Cerebral amyloid angiopathy, R01, age, cerebral, cerebral amyloid angiopathy, cognitive impairment, cortical superficial siderosis, haemorrhagic lesion, haemorrhagic lesions, intracerebral haemorrhages, neuropathologists, patient, patients, small vessel disease, spontaneous intracerebral haemorrhage, transient focal neurological episodes, white matter hyperintensities
Author NameAffiliation
Matthew P FroschMassachusetts General Hospital
Matthew P FroschMassachusetts General Hospital
Sebastian BrandnerStroke Research Centre, University College London Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery
Christian MawrinOtto-von-Guericke University
Pascale VarletGroupe Hospitalier Universitaire (GHU) Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris, INSERM UMR-S6, Universite Paris Cite
Pascale VarletGroupe Hospitalier Universitaire (GHU) Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris, INSERM UMR-S6, Universite Paris Cite
Anand ViswanathanJ Philip Kistler Research Center, Massachusetts General Hospital
Eric E SmithUniversity of Calgary
Steven M GreenbergJ Philip Kistler Research Center, Massachusetts General Hospital
  • 1 - 9

Datasets

Release 1.2